Provided by Tiger Fintech (Singapore) Pte. Ltd.

Icon PLC

139.11
+4.293.18%
Post-market: 139.110.00000.00%17:56 EDT
Volume:980.39K
Turnover:135.96M
Market Cap:11.05B
PE:15.14
High:139.72
Open:135.24
Low:135.01
Close:134.82
Loading ...

ICON plc CEO to Present at William Blair Annual Growth Stock Conference

Reuters
·
27 May

Icon price target lowered to $144 from $232 at Redburn Atlantic

TIPRANKS
·
23 May

ICON Plc : Mizuho Cuts Target Price to $173 From $200

THOMSON REUTERS
·
15 May

Stock Track | Icon PLC Plummets 5.01% as Truist Securities Slashes Price Target

Stock Track
·
07 May

Stock Track | ICON PLC Plummets 5.01% as Truist Securities Slashes Target Price

Stock Track
·
07 May

Truist Securities Adjusts Price Target on ICON to $190 From $208, Keeps Buy Rating

MT Newswires Live
·
06 May

Icon Is Maintained at Neutral by Baird

Dow Jones
·
02 May

Icon PLC (ICLR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives

GuruFocus.com
·
02 May

ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down

Zacks
·
01 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Icon (ICLR), Reviva Pharmaceuticals Holdings (RVPH) and SurModics (SRDX)

TIPRANKS
·
01 May

Icon PLC (ICLR) Beats Q1 Earnings Estimates

Zacks
·
01 May

ICON PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Icon Q1 Adjusted Earnings, Revenue Fall

MT Newswires Live
·
01 May

Is ICON Public Limited (ICLR) One of the Oversold Global Stocks to Buy According to Hedge Funds?

Insider Monkey
·
01 May

BRIEF-Icon Reports First Quarter 2025 Results

Reuters
·
01 May

Icon Q1 Adj. EPS $3.19 Beats $3.13 Estimate, Sales $2.00B Miss $2.02B Estimate

Benzinga
·
01 May

ICON Plc: Co's Performance in Q1 Impacted by Volatility & Cautiousness That Continues to Be Present in Broader Clinical Development Market

THOMSON REUTERS
·
01 May

ICON Plc Outlook FY Adj EPS $12.75 to $14.25

THOMSON REUTERS
·
01 May

ICON Reports First Quarter 2025 Results

Business Wire
·
01 May

What to Expect From These 3 MedTech Stocks This Earnings Season?

Zacks
·
29 Apr